Compare CNC & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNC | ALC |
|---|---|---|
| Founded | 1984 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 32.6B |
| IPO Year | 2001 | 2002 |
| Metric | CNC | ALC |
|---|---|---|
| Price | $68.05 | $71.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 27 |
| Target Price | $74.50 | ★ $81.98 |
| AVG Volume (30 Days) | ★ 3.9M | 1.5M |
| Earning Date | 10-27-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.15 | N/A |
| Revenue | ★ $194,777,000,000.00 | N/A |
| Revenue This Year | $12.83 | $6.59 |
| Revenue Next Year | N/A | $6.04 |
| P/E Ratio | ★ $13.27 | $38.31 |
| Revenue Growth | ★ 19.44 | N/A |
| 52 Week Low | $31.63 | $61.84 |
| 52 Week High | $72.50 | $87.64 |
| Indicator | CNC | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 67.83 |
| Support Level | $63.36 | $66.08 |
| Resistance Level | $68.67 | $73.52 |
| Average True Range (ATR) | 2.70 | 1.22 |
| MACD | -0.21 | 0.69 |
| Stochastic Oscillator | 33.09 | 89.45 |
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.